+ All Categories
Home > Documents > THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial...

THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial...

Date post: 04-Jul-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
26
Antimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS, CCNS, CCRN, PCCN Critical Care Dominic Chan, PharmD, BCPS AQ-ID Infectious Diseases & Antimicrobial Stewardship
Transcript
Page 1: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Antimicrobial Stewardship

THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER

Polly Hansen, RN, MN, CNS, CCNS, CCRN, PCCNCritical Care

Dominic Chan, PharmD, BCPS AQ-IDInfectious Diseases & Antimicrobial Stewardship

Page 2: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

DISCLOSURES

• Dominic Chan• Financial: Contracted grant with the Oregon Health Authority and the CDC

Antimicrobial Use Module; provides fee-for-service consultation for development and optimization of health system antimicrobial stewardship programs

• Non-financial: Washington State Hospital Association antimicrobial stewardship steering committee. Dominic receives no compensation as a member.

• Polly Hansen• Polly has no relevant financial or nonfinancial relationships to disclose

Page 3: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Learning Objectives

• Summarize the goals of antimicrobial stewardship

• Explain the unique role nurses play in healthcare that enhance antimicrobial stewardship

• Identify and assess examples of opportunities for nurses in antimicrobial stewardship

• List 2 special considerations related to antibiotic therapy

Page 4: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Impact of Antimicrobial Consumption

The result?1. Increased adverse events

• Higher risk of Clostridium difficile (C. diff)• Drug toxicity (e.g., adverse drug reactions, rash)

2. Development of antimicrobial resistance• Higher risk of antibiotic-resistant organisms

3. Higher cost of care• Higher cost of pharmaceuticals• Increased length of stay due to complications

At least 30% of inpatient antimicrobial consumption is unnecessary

Page 5: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Antimicrobial Stewardship Programs Defined

Programs that aim to improve antibiotic prescribing in order to:• Improve outcomes of patients with infections• Minimize adverse effects such as C.diff and drug toxicity• Reduce healthcare costs

Multidisciplinary teams that focus on treating patients with the right antibiotic at the right dose for the right duration of time

Required by the Joint Commission to oversee and monitor antimicrobial use

Recommended by the Centers for Disease Control and Prevention, the Infectious Disease Society of America and the Society for Healthcare Epidemiology of America

ANTIMICROBIAL STEWARDSHIP PROGRAMS ARE

Page 6: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Antibiotic Resistance

CDC 2015

Antibiotic Introduced Resistance Identified Years

Penicillin 1942 1945 3

Tetracycline 1950 1959 9

Erythromycin 1953 1968 15

Methicillin 1959 1962 3

Gentamicin 1967 1979 11

Vancomycin 1972 1988 16

Imipenem 1985 1998 13

Ceftazidime 1985 1987 2

Levofloxacin 1996 1996 0

Linezolid 2000 2001 1

Daptomycin 2003 2005 2

Ceftaroline 2010 2011 1

“The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdosehimself and by exposing his microbes to non-lethal quantities of the drug make them resistant.”

~Alexander FlemingDiscoverer of penicillin

Nobel Lecture, 1945

Page 7: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Neisseria gonorrhea: A tale of resistance

MMWR 2012; CDC 2016

Top: Distribution of antibiotics used to treat gonorrhea

Bottom: US Gonorrhea resistance rates

Cipro not recommended: 2000: Acquired in Asia 2002: Acquired in CA 2004: In MSM 2006: NEVER

Page 8: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Staphylococcus aureus: A tale of resistance

S aureus(PSSA)

Penicillin Resistant,Methicillin-Susceptible

S aureus(MSSA)

[beta-lactamase]

PenicillinMethicillin

&Vancomycin

Methicillin ResistantS aureus (MRSA)

[altered PBP]

Vancomycin Intermediate-Resistant S aureus

(VISA) [thickened cell wall]

{MIC 4-16}

Vancomycin ResistantS aureus (VRSA)

[altered precursors]{MIC>32}

Vancomycin TolerantS aureus

{MIC 2-4}

and

DaptomycinVancomycinreformulated

Daptomycin ResistantS aureus

[altered PBP]

Boucher & Sakoulas. CID 2007

Page 9: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Antimicrobial Stewardship Programs Defined

Multidisciplinary teams that focus on treating patients with the right antibiotic at the right dose for the right duration of time

ANTIMICROBIAL STEWARDSHIP PROGRAMS ARE

Who’s missing?

Page 10: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Nurses

Physicians

Pharmacists

I D

Rita Olans, DNP, CPNP, APRN-BC

Page 11: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Nursing Influence Over Antimicrobial Stewardship

• Discipline closest to patient for longest period of time

• Positioned for patient education

• Established role as patient advocate

• Involved in most antimicrobial stewardship (AMS) activities

Presenter
Presentation Notes
Objective 2
Page 12: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Staff Nurse• Intake assessment

• Medication history• Home meds• Recent antibiotics • Medication reconciliation

• Medical history• Recent infections

• Isolation status

• Allergies

Clinical Nurse Specialist

AMS Opportunities: On Admission

Develops intake form or document flowsheet

Implement medication reconciliation process

Infection Control CNS collaborates to develop isolation policies

Page 13: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Staff Nurse• Obtaining cultures

• Timely ordering and administration• Sepsis; Pneumonia• Vaccinations: Flu; Pneumonia

• Documentation serves to communicate

• Monitors adverse events of antibiotic administration

• Acknowledge/Review orders forprescribed antibiotics

• Handoff communication

• Participate in rounds

• Care-team communication

Clinical Nurse Specialist

AMS Opportunities: Daily Care

Education re: culturing procedures

Develops sepsis recognition tools

Develops/implements nurse-driven vaccination protocols

Writes prescriptions for ABOs

Establishes patient rounds

Facilitates provider communication

Page 14: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Staff Nurse

• Discharge readiness assessment• Begin on admission

• Transition from IV to PO route

• Assess ability to manage PO meds

• Post discharge success• Patient education

• Follow up visits

• Provide after visit summary

Clinical Nurse Specialist

AMS Opportunities: Upon Discharge

Implement teach-back method of education

Develop patient education materials

Develop after visit summaryImplement strategies to increase

medication adherence

Presenter
Presentation Notes
Patient education Med rec IV therapy at home? Side effect teaching
Page 15: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Harold Standiford and team looked at monitoring the cost of using antimicrobial agents over a seven year period

• Costs decreased from $44,181 at baseline to $23,933 (a 45.8% decrease)

• There was a reduction of approximately $3 million within the first 3 years, mostly from decreasing antifungal use in patients with cancer.

• One year after the program was discontinued, antimicrobial costs increased from $23,933 to $31,653 (a 32.3% increase within 2 years) mostly in the antibacterial category.

Standiford, et al. Inf Con & Hosp Epid 2012.

Clinical Studies

Page 16: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Elizabeth Gillespie and team looked at the involvement of nurses as a means of improving AMS. The attitudes and antimicrobial stewardship knowledge of nurses were assessed before and after an education intervention that focused on antimicrobial management.

• Following education there was an articulated increase from14% to 42% of instances where nurses said they would question the need for intravenous antibiotics.

• There was improved awareness of the risk of development of resistance from 59% to 79%.

• Knowledge of the associated risk of line-related infection with intravenous therapy,increased from 38% to 70%.

Gillespie, et al. AJIC 2013.

Clinical Studies

Page 17: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Declining Antibiotic Approvals in the Past 30+ Years

02468

1012141618

Spellberg, et al. CID 2004; Centerwatch.com, accessed 9/28/2017

Page 18: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

• Engage in Four Core Actions

• Find out how we can become more involved with AMS as CNSs

• What’s out there?• How do we position ourselves in decision

making roles

• Identify the impact of the CNS on AMS• Research • Clinical Inquiry

• Provide education about AMS and nursing activities related to AMS

• Facilitate the development of new antibiotics

FOUR CORE ACTIONS

1.PREVENTING INFECTIONS,PREVENTING SPREAD.

2. TRACKING RESISTANCE PATTERNS.

3. IMPROVING USE OF ANTIBIOTICS.

4. DEVELOPING NEW ANTIBIOTICS AND DIAGNOSTIC TESTS.

Next Steps

Presenter
Presentation Notes
Objective 3
Page 19: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Next Steps in Action: Classic Real Life Story

Adult in LTC loses glasses

EDUrine culture*

+Ceftriaxone

NauseatedUrinanalysis + Cipro *

More confused

Dehydrated

Improves on IV fluids

Urine Culture: CTX resistant

Kleb *Cefepime

Clostridium difficile

*Opportunities to intervene

Page 20: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Signs and symptoms differentiate ASB versus UTI

BACTERURIA

ASB UTI

Bacteruria: The presence of bacteria in urineThere is NO TEST to differentiate asymptomatic bacteruria (ASB) versus UTI

Page 21: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Why:Chronically-catheterized pts have bacteriuria98% of the time.John Warren, JID 1982

FeverRigorsMalaise/lethargyFlank pain/CVA tendernessFoul-smelling urineAcute hematuria

Pelvic discomfortChange in urine colorCloudy urineUrinary sedimentDeliriumDysuria, urgency, frequency

Why:Pyelonephritis and Bacteruria: A Major Problem inPreventative MedicineEdward Kass, Ann Intern Med, 1962

Urinary Tract InfectionsSome common “signs” are not true criteria

Page 22: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

• 98% Urine cultures from catheterized non-infected patients grew bacteriaJW Warren, et al. J Infect Dis., 1982

• Yet, 30 – 68% of asymptomatic patients with positive urine are treatedTrautner, et al. ID Clin Nor Amer., 2014.

The bladder is likely NOT a sterile siteChallenging Commonly Held Beliefs

Page 23: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

When encountering an “infected” patient:

• Consider the presenting symptoms – Ask questions.

• Consider the “positive” laboratory results – Ask questions.

• Consider the antibiotic order– Ask questions.

Page 24: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Good nursing is good stewardship and good antibiotic stewardship

is good nursing

Page 25: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

References• Center for Disease Control and Prevention. (2015). Antibiotic/Antimicrobial Resistance. Retrieved from

https://www.cdc.gov/drugresistance/about.html.

• Gillespie, E., Rodrigues, A., Wright, L. & Sturart, R. L. (2013). Improving antibiotic stewardship by involving nurses. American Journal of Infection Control. Volume 41, p. 365-367.

• Ladenheim, D., Rosembert, D., Hallam, C.,& Micallef, C. (2013). Antimicrobial stewardship: the role of the nurse. Nursing Standard. 28(6), p. 46-49. (4p).

• Olans, R. D., Olans, R. N. & Witt, D. J. (2017). Good Nursing Is Good Antibiotic Stewardship. American Journal of Nursing, 117 (8), p 58-63.

• Olans, R. N., Lonas, R. D. & DeMaria Jr., A. (2016). The Critical Role of the Staff Nurse in Antimicrobial Stewardship - Unrecognized, but Already There. Clinical Infectious Disease. 62 (1). p. 84-89.

• Standiford, H., Chan, S., Tripoli, M., Weekes, E., & Forrest, G. (2012). Antimicrobial Stewardship at a Large Tertiary Care Academic Medical Center: Cost Analysis Before, During, and After a 7-Year Program. Infection Control & Hospital Epidemiology, 33(4), 338-345. doi:10.1086/664909

• The Joint Commission. (2017). Retrieved from https://www.jointcommission.org/antimicrobial_stewardship_faqs/

• Thompson, C. A. (2017). Antimicrobial stewardship in hospitals to become national requirement. American Journal of Health-system Pharmacy. 73 (5), p. 1112-1116.

Page 26: THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER › ... › OCCNS_NACNS_2017-10-30.pdfAntimicrobial Stewardship THE CLINICAL NURSE SPECIALIST AS STAKEHOLDER Polly Hansen, RN, MN, CNS,

Recommended